0.8(top 50%)
impact factor
33.0K(top 1%)
papers
1.6M(top 1%)
citations
412(top 1%)
h-index
0.8(top 50%)
impact factor
38.1K
all documents
1.7M
doc citations
631(top 1%)
g-index

Top Articles

#TitleJournalYearCitations
1Role of Insulin Resistance in Human DiseaseDiabetes198810,677
2Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose IntoleranceDiabetes19795,711
3Metabolic Endotoxemia Initiates Obesity and Insulin ResistanceDiabetes20074,964
4Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet–Induced Obesity and Diabetes in MiceDiabetes20083,897
5Banting lecture 1988. Role of insulin resistance in human diseaseDiabetes19883,748
6 -Cell Deficit and Increased  -Cell Apoptosis in Humans With Type 2 DiabetesDiabetes20033,615
7Method for the Isolation of Intact Islets of Langerhans from the Rat PancreasDiabetes19672,925
8Role of Oxidative Stress in Development of Complications in DiabetesDiabetes19912,551
9A Preprandial Rise in Plasma Ghrelin Levels Suggests a Role in Meal Initiation in HumansDiabetes20012,550
10The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDMDiabetes19882,466
11Reviewers of ManuscriptsDiabetes19912,465
12Immunoassay of Insulin: Two Antibody System: Plasma Insulin Levels of Normal, Subdiabetic and Diabetic RatsDiabetes19632,403
13From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes MellitusDiabetes20092,251
14Role of oxidative stress in diabetic complications: a new perspective on an old paradigmDiabetes19992,190
15Nonalcoholic Fatty Liver Disease: A Feature of the Metabolic SyndromeDiabetes20012,100
16Dysfunction of Mitochondria in Human Skeletal Muscle in Type 2 DiabetesDiabetes20021,975
17U.K. Prospective Diabetes Study 16: Overview of 6 Years' Therapy of Type II Diabetes: A Progressive DiseaseDiabetes19951,798
18Circulating Ghrelin Levels Are Decreased in Human ObesityDiabetes20011,786
19Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary SyndromeDiabetes19891,697
20Morbidity and Mortality in Diabetics In the Framingham Population: Sixteen Year Follow-up StudyDiabetes19741,666
21PPAR-gamma: adipogenic regulator and thiazolidinedione receptorDiabetes19981,659
22High Incidence of Metabolically Active Brown Adipose Tissue in Healthy Adult HumansDiabetes20091,650
23The Effect of Insulin on the Disposal of Intravenous Glucose: Results from Indirect Calorimetry and Hepatic and Femoral Venous CatheterizationDiabetes19811,647
24Short-Chain Fatty Acids Stimulate Glucagon-Like Peptide-1 Secretion via the G-Protein–Coupled Receptor FFAR2Diabetes20121,644
25Butyrate Improves Insulin Sensitivity and Increases Energy Expenditure in MiceDiabetes20091,630
26PPAR  Ligands Increase Expression and Plasma Concentrations of Adiponectin, an Adipose-Derived ProteinDiabetes20011,591
27Five-Year Follow-Up After Clinical Islet TransplantationDiabetes20051,489
28Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDMDiabetes19971,402
29High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cellsDiabetes20001,379
30Are Oxidative Stress-Activated Signaling Pathways Mediators of Insulin Resistance and  -Cell Dysfunction?Diabetes20031,351
31Banting Lecture 1980: of Pregnancy and ProgenyDiabetes19801,338
32NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and OlderDiabetes20031,332
33Quantification of the Relationship Between Insulin Sensitivity and β-Cell Function in Human Subjects: Evidence for a Hyperbolic FunctionDiabetes19931,302
34Role of Low Energy Expenditure and Sitting in Obesity, Metabolic Syndrome, Type 2 Diabetes, and Cardiovascular DiseaseDiabetes20071,301
35Preservation of Pancreatic  -Cell Function and Prevention of Type 2 Diabetes by Pharmacological Treatment of Insulin Resistance in High-Risk Hispanic WomenDiabetes20021,298
36Mechanisms of Pancreatic  -Cell Death in Type 1 and Type 2 Diabetes: Many Differences, Few SimilaritiesDiabetes20051,296
37Pathologic Anatomy of the Pancreas in Juvenile Diabetes MellitusDiabetes19651,295
38Inflammatory Cytokines and the Risk to Develop Type 2 Diabetes: Results of the Prospective Population-Based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam StudyDiabetes20031,282
39Estimation of Insulin Secretion Rates from C-Peptide Levels: Comparison of Individual and Standard Kinetic Parameters for C-Peptide ClearanceDiabetes19921,263
40Automated Method for Isolation of Human Pancreatic IsletsDiabetes19881,236
41Lipid-Induced Insulin Resistance in Human Muscle Is Associated With Changes in Diacylglycerol, Protein Kinase C, and I B- Diabetes20021,216
42Effect of Insulin and Glucose Infusions on Sympathetic Nervous System Activity in Normal ManDiabetes19811,199
43Protein kinase C activation and the development of diabetic complicationsDiabetes19981,197
44The Relationship of Glycemic Exposure (HbA1c) to the Risk of Development and Progression of Retinopathy in the Diabetes Control and Complications TrialDiabetes19951,184
45Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic ratsDiabetes19991,161
46Role of oxidative stress in development of complications in diabetesDiabetes19911,139
47Prospective Analysis of The Insulin-Resistance Syndrome (Syndrome X)Diabetes19921,102
48Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibshipsDiabetes20001,099
49Type 2 Diabetes, APOE Gene, and the Risk for Dementia and Related Pathologies: The Honolulu-Asia Aging StudyDiabetes20021,097
50Visceral Fat Adipokine Secretion Is Associated With Systemic Inflammation in Obese HumansDiabetes20071,094